Senators Demand Mylan Justify EpiPen Price Hikes

August 22, 2016 9:02 PM

23 0

U.S. Senators are scrutinizing the rising price of EpiPens following a public outcry over the 400 percent price hike since 2008.

On Monday, Senator Charles Grassley of Iowa, chairman of the Senate Judiciary Committee, sent a letter to Heather Bresch, chief executive officer of Mylan, the maker of EpiPens. The letter, which cited earlier NBC News reporting, said he was "concerned that the substantial price increase could limit...

Read more

To category page